UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
UBcare wins patent for tech to monitor suspected infectious diseases
UBcare, a company specializing in digital healthcare solutions, said Friday...
by Shim Hyun-tai
|
2020-09-04 18:04
라인
Chong Kun Dang to conduct P2 trials of Covid-19 therapy in Russia
Chong Kun Dang's anticoagulant and acute pancreatitis treatment Nafabel...
by Shim Hyun-tai
|
2020-09-03 12:36
라인
Recovered Covid-19 patients suffer from aftereffects – for long
Many Covid-19 patients have been completely cured by enduring physical and ...
by Shim Hyun-tai
|
2020-09-02 20:12
라인
Nation struggles to secure beds, workforce for severe Covid-19 patients
The Ministry of Health and Welfare is securing more sickbeds and training m...
by Shim Hyun-tai
|
2020-09-02 16:15
라인
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
JW Pharmaceutical said Tuesday that its rheumatoid arthritis drug, Actemra ...
by Shim Hyun-tai
|
2020-09-02 14:08
라인
Korea approved 22 clinical studies for Covid-19 vaccines, treatments
The Ministry of Food and Drug Safety said it has approved 22 clinical trial...
by Shim Hyun-tai
|
2020-09-01 18:02
라인
MedPacto’s oncology pipeline for blood cancer wins EU patent
MedPacto said Tuesday that it has obtained a European patent for a pharmace...
by Shim Hyun-tai
|
2020-09-01 17:14
라인
MSD’s antiviral Prevymis gains insurance coverage
MSD Korea said that the Ministry of Health and Welfare has granted insuranc...
by Shim Hyun-tai
|
2020-09-01 15:05
라인
T&R Biofab gains sales rights of pluripotent stem cell-derived cardiomyocyte
T&R Biofab has signed a licensing agreement with iPS Academia Japan to secu...
by Shim Hyun-tai
|
2020-09-01 14:13
라인
MSD Korea’s Keytruda wins 2 new indications for treating cancer
MSD Korea’s immunotherapy Keytruda (ingredient: pembrolizumab) obtained two...
by Shim Hyun-tai
|
2020-08-31 16:44
라인
China gives nod to Huonland’s eye drop for allergic inflammation
Huonland, a joint venture between Huons and Beijing Northland, said Monday ...
by Shim Hyun-tai
|
2020-08-31 15:28
라인
SNUH to introduce Toshiba’s heavy ion radiotherapy device
Seoul National University Hospital (SNUH) signed a contract on Monday to in...
by Shim Hyun-tai
|
2020-08-31 14:02
라인
‘AI MRI model can diagnose autism’s severity, prognosis’
A Severance-KAIST research team has affirmed that deep learning using brain...
by Shim Hyun-tai
|
2020-08-28 18:04
라인
Regulator names 2 more innovative medical devices
The Ministry of Food and Drug Safety has designated clinical decision suppo...
by Shim Hyun-tai
|
2020-08-28 18:03
라인
Takeda’s Alunbrig available as primary therapy for lung cancer
The Ministry of Food and Drug Safety has approved Takeda Korea’s Alunbrig (...
by Shim Hyun-tai
|
2020-08-28 15:52
라인
Capital area tops Daegu as Covid-19 epicenter
Korea’s new virus cases sank below 400 on Thursday but cluster infections c...
by Shim Hyun-tai
|
2020-08-28 14:54
라인
‘Thyroid surgery using oral endoscopy reduces swallowing difficulties’
A research team of Seoul National University (SNU) Boramae Medical Center r...
by Shim Hyun-tai
|
2020-08-27 18:06
라인
SNUH opens new Covid-19 treatment center in 2 days
Seoul National University Hospital (SNUH) said Thursday that it opened a la...
by Shim Hyun-tai
|
2020-08-27 18:06
라인
Genexine's cytokine drug effective on severe Covid-19 patients
Genexine said Thursday that it has confirmed the safety and efficacy of lon...
by Shim Hyun-tai
|
2020-08-27 18:05
라인
New virus cases reach six-month high; tightest restrictions imminent
Korea reported new Covid-19 cases of more than 400 for the first time in si...
by Shim Hyun-tai
|
2020-08-27 13:24
-
1
2
3
4
5
6
7
8
9
10
다음
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top